Remove Consultants Remove Mergers and Acquisitions Remove Securities and Exchange Commission (SEC)
article thumbnail

Globus Medical (GMED) Q1 2024 Earnings Call Transcript

The Motley Fool

Our Form 10-K for the 2023 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website.

article thumbnail

Globus Medical (GMED) Q2 2024 Earnings Call Transcript

The Motley Fool

Our form 10-K for the 2023 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward looking statements made today. Our SEC filings, including the 10-K, are available on our website.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Globus Medical (GMED) Q3 2024 Earnings Call Transcript

The Motley Fool

Our Form 10-K for the 2023 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website.

article thumbnail

What Happens If My StockBroker Goes Out of Business

Hedgestone

Here are the steps you need to follow: Step 1: Contact the Securities Investor Protection Corporation (SIPC) The Securities Investor Protection Corporation (SIPC) is a non-profit organization that provides insurance to investors in the event that their brokerage firm goes out of business.

article thumbnail

Globus Medical (GMED) Q3 2023 Earnings Call Transcript

The Motley Fool

Our Form 10-K for the 2022 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website.

article thumbnail

S&P; Global (SPGI) Q2 2024 Earnings Call Transcript

The Motley Fool

The matters discussed in today's conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including projections, estimates and descriptions of future events. Securities and Exchange Commission, including our most recently filed Form 10-K.

article thumbnail

NTx Partners with Ginkgo Bioworks; Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins

Anzu Partners

As a performer on DARPA’s Reimagining Protein Manufacturing (RPM) project, Ginkgo aims to deliver revolutionary advances in on-demand protein manufacturing by leveraging Cell-Free Protein Synthesis (CFPS) to enable rapid, high-yield, distributed production of human therapeutic proteins that support national security objectives.